Published on 01 January 2021

An open label phase Ⅰ/Ⅱa clinical trial of 11β-HSD1 inhibitor for overt and subclinical Cushing’s syndrome; Supplementary materials

Oda, Satoko;Ashida, Kenji;Uchiyama, Makiko;Hasuzawa, Nao;Nagayama, Ayako;Wang, Lixiang;Nagata, Hiromi;Kishimoto, Junji;Todaka, Koji;Nakanishi, Yoichi;Nomura, Masatoshi

Description

Supplementary materials

Citations (0)

No citations found

It looks like this dataset has no citations.

Mentions (0)

No mentions found

It looks like this dataset has not been mentioned in any sources.

Metrics

Dataset Index

0.3

FAIR Score

13%

Citations

Mentions

Metrics Over Time

Publication Details

DOI

10.6084/m9.figshare.14406368

Publisher

figshare

Assigned Domain

Subfield

Endocrinology, Diabetes and Metabolism

Field

Medicine

Domain

Health Sciences

Confidence Score

100%

Source

Open Alex

Keywords

EndocrinologyAged health care

Normalization Factors

15.38

CTw

1.00

MTw

1.00